These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6230988)

  • 21. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P; Renaudin H; Quentin C; Bebear C
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
    Gay JD; DeYoung DR; Roberts GD
    Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro and in vivo antibacterial activity of AT-2266.
    Kouno K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1983 Jul; 24(1):78-84. PubMed ID: 6226242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of ciprofloxacin (Bay o 9867).
    Fass RJ
    Antimicrob Agents Chemother; 1983 Oct; 24(4):568-74. PubMed ID: 6228192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gyrase inhibitor].
    Forth W
    Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraphagocytic bactericidal activity of bacterial DNA gyrase inhibitors against Serratia marcescens.
    Traub WH
    Chemotherapy; 1984; 30(6):379-86. PubMed ID: 6097410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity of norfloxacin.
    Norrby SR; Jonsson M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of norfloxacin against Chlamydia trachomatis.
    Meier-Ewert H; Weil G; Millott G
    Eur J Clin Microbiol; 1983 Jun; 2(3):271-2. PubMed ID: 6224687
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections.
    Hirai K; Ito A; Abe Y; Suzue S; Irikura T; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Jan; 19(1):188-9. PubMed ID: 6454381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Wise R; Andrews JM; Edwards LJ
    Antimicrob Agents Chemother; 1983 Apr; 23(4):559-64. PubMed ID: 6222695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
    Machka K
    Eur J Clin Microbiol; 1984 Aug; 3(4):374. PubMed ID: 6237906
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Petermüller C
    Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin.
    Zackrisson G; Brorson JE; Björnegård B; Trollfors B
    J Antimicrob Chemother; 1985 May; 15(5):629-32. PubMed ID: 2861190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.
    Diez-Enciso M; Mas-Jimenez G; Velasco-Cerrudo A; Gutierrez-Altes A
    Eur J Clin Microbiol; 1984 Aug; 3(4):367. PubMed ID: 6237905
    [No Abstract]   [Full Text] [Related]  

  • 39. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L; Saunders J; Traynor R; Koornhof HJ
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
    Goossens H; De Mol P; Coignau H; Levy J; Grados O; Ghysels G; Innocent H; Butzler JP
    Antimicrob Agents Chemother; 1985 Mar; 27(3):388-92. PubMed ID: 3158276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.